<DOC>
	<DOC>NCT00344370</DOC>
	<brief_summary>This is a sixteen-week double-blind active-controlled follow-on and 28-week single-blind extension study for patients who participated in study NK-104-305.</brief_summary>
	<brief_title>Follow-On Study of Pitavastatin Versus Atorvastatin in Patients With Type II Diabetes Mellitus and Combined Dyslipidemia</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Dyslipidemias</mesh_term>
	<mesh_term>Diabetes Mellitus, Type 2</mesh_term>
	<mesh_term>Atorvastatin Calcium</mesh_term>
	<mesh_term>Pitavastatin</mesh_term>
	<criteria>Type II diabetes mellitus Combined dyslipidemia Completed NK104305 (NCT00309751) Withdrawal from NK104305 (NCT00309751)</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2010</verification_date>
	<keyword>Pitavastatin</keyword>
	<keyword>Type II Diabetes Mellitus</keyword>
	<keyword>Combined Dyslipidemia</keyword>
</DOC>